Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the second quarter of 2026.
In this edition, a UK settlement ends nil–nil, pending BIPA claims are retroactive per scan, and a lodestar multiplier isn’t mathing. Plus, we have our usual coverage of lawsuits involving drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more. This edition’s video features litigation trends and developments in the fintech industry.
We wrap up the Roundup with a summary of class action settlements finalized in the second quarter.